You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Adapting OSD Capital Project Design to Continuous Manufacturing

Apr 01, 2016

Insights

Adapting OSD Capital Project Design to Continuous Manufacturing

Apr 01, 2016

The Food and Drug Administration (FDA), led by Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER), is tirelessly and relentlessly promoting continuous manufacturing (CM) as the best opportunity to achieve its 21st Century Quality vision "...a maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high-quality drugs without extensive regulatory oversight."

To read more go to http://digital.pharmpro.com/pharmaceuticalproducts/ips_interphex_tour_april_2016?pg=16#pg16

Related Experts

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue